FAM168A and chronic myelogenous leukemia, BCR-ABL1 positive: FAM168A interference inhibited K562 cell proliferation and significantly reduced AKT1 phosphorylation, suggesting that FAM168A may mediate CML cell proliferation through AKT1 phosphorylation.